1.
Ariza Cadena F. Strategies to Reduce the Most Frequent Adverse Events of Neuromuscular Blocking Agents. Colomb. J. Anesthesiol. [Internet]. 2012 Apr. 1 [cited 2024 Apr. 29];40(2):127-30. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/822